Page last updated: 2024-09-03

3-quinuclidinyl-4-iodobenzilate and Schizophrenia

3-quinuclidinyl-4-iodobenzilate has been researched along with Schizophrenia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Raedler, TJ1

Other Studies

1 other study(ies) available for 3-quinuclidinyl-4-iodobenzilate and Schizophrenia

ArticleYear
Comparison of the in-vivo muscarinic cholinergic receptor availability in patients treated with clozapine and olanzapine.
    The international journal of neuropsychopharmacology, 2007, Volume: 10, Issue:2

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain Chemistry; Clozapine; Dose-Response Relationship, Drug; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Quinuclidinyl Benzilate; Radiopharmaceuticals; Receptors, Muscarinic; Schizophrenia; Schizophrenic Psychology; Tomography, Emission-Computed, Single-Photon

2007